Back to top
Top
CMS Measure ID:
Version:
7
NQF Number:
22
Performance/Reporting Period
2019
Description:

Percentage of patients 65 years of age and older who were ordered high-risk medications. Two rates are reported.

a. Percentage of patients who were ordered at least one high-risk medication.

b. Percentage of patients who were ordered at least two of the same high-risk medications.

Data Elements contained within the eCQM + Expand all

Value Set Description from VSAC
Clinical Focus: This value set grouping contains concepts that represent annual wellness visits.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an annual wellness visit.
Inclusion Criteria: Includes only relevant concepts associated with encounters specific to annual wellness visits.
Exclusion Criteria: No exclusions.

Constrained to codes in the Encounter, Performed: Annual Wellness Visit 1 value set (2.16.840.1.113883.3.526.3.1240)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients living in assisted living, domiciliary care or rest homes who have had an interaction with a member of their medical team.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with services provided to new and established patients living in assisted living, domiciliary care or rest home. This is a grouping value set of CPT codes.
Exclusion Criteria: Excludes visits in settings other than assisted living, domiciliary care or rest homes.

Constrained to codes in the Encounter, Performed: Care Services in Long-Term Residential Facility value set (2.16.840.1.113883.3.464.1003.101.12.1014)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients who have been discharged from a nursing facility.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with discharge from a nursing facility, including a final examination, instructions for continuing care and preparation of discharge records, prescriptions, and referral forms. Discharge services encounters can be less than or over 30 minutes. This is a grouping of CPT codes.
Exclusion Criteria: Excludes discharges from settings other than a nursing facility.

Constrained to codes in the Encounter, Performed: Discharge Services - Nursing Facility value set (2.16.840.1.113883.3.464.1003.101.12.1013)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent the most common inpatient encounter types.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter. The intent of this data element is to identify patients who have had an inpatient encounter.
Inclusion Criteria: Includes only relevant concepts associated with SNOMED CT codes representing inpatient encounter.
Exclusion Criteria: No exclusions.

Constrained to codes in the Encounter, Performed: Encounter Inpatient value set (2.16.840.1.113883.3.666.5.307)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients who have had a home health visit by a provider for the evaluation or management of a new or existing patient.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with home visits for the evaluation and management of a new or established patient. This is a grouping value set of CPT and SNOMED CT codes.
Exclusion Criteria: No exclusions.

Constrained to codes in the Encounter, Performed: Home Healthcare Services value set (2.16.840.1.113883.3.464.1003.101.12.1016)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients who have had an interaction with a member of their medical team on admission to a nursing facility.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with services provided to new and established patients in a nursing facility (skilled, intermediate and long-term care facilities).
Exclusion Criteria: Excludes visits in settings other than a nursing facility.

Constrained to codes in the Encounter, Performed: Nursing Facility Visit value set (2.16.840.1.113883.3.464.1003.101.12.1012)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients who have had an office or other outpatient visit.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with comprehensive history, evaluation, and management of a patient in an office or outpatient facility. Patient can be presenting with problems that are minor to high severity. This is a grouping value set of CPT codes.
Exclusion Criteria: Excludes non-office visits, including telehealth services.

Constrained to codes in the Encounter, Performed: Office Visit 1 value set (2.16.840.1.113883.3.464.1003.101.12.1001)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent ophthalmological visits.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Encounter.
Inclusion Criteria: Includes only relevant concepts associated with relevant encounters during which the patient sees an eye care professional.
Exclusion Criteria: No exclusions.

Constrained to codes in the Encounter, Performed: Ophthalmologic Outpatient Visit value set (2.16.840.1.113883.3.464.1003.101.11.1206)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients over the age of 18 who have had an established preventive care office visit.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with comprehensive preventive medicine reevaluation and management of an individual over the age of 18. This is a grouping value set of CPT codes.
Exclusion Criteria: Excludes non-office visits, including telehealth services.

Constrained to codes in the Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up 1 value set (2.16.840.1.113883.3.464.1003.101.12.1025)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients over the age of 18 who have had an initial preventive care office visit.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Encounter, Performed.
Inclusion Criteria: Includes only relevant concepts associated with comprehensive preventive medicine reevaluation and management of an individual over the age of 18. This is a grouping value set of CPT codes.
Exclusion Criteria: Excludes non-office visits, including telehealth services.

Constrained to codes in the Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up 1 value set (2.16.840.1.113883.3.464.1003.101.12.1023)

QDM Datatype and Definition (QDM Version 5.3)

Encounter, Performed

Data elements that meet criteria using this datatype should document that the encounter indicated by the QDM category and its corresponding value set is in progress or has been completed.

Timing: The Relevant Period addresses:

  • startTime – the time the encounter began (admission time)
  • stopTime – the time the encounter ended (discharge time)

The Author dateTime addresses when an Encounter is documented. Documentation can occur at the beginning, during, at the end or subsequent to the end of an Encounter. The Author dateTime should be used only if the Relevant Period cannot be obtained.

The Location Period is an attribute of the attribute facility location addresses:

  • startTime - the time the patient arrived at the location;
  • stopTime - the time the patient departed from the location

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients receiving hospice care outside of a hospital or long term care facility.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Order or Intervention, Order. The intent of this value set is to identify all patients receiving hospice care outside of a hospital or long term care facility.
Inclusion Criteria: Includes only relevant concepts associated with hospice care concepts.
Exclusion Criteria: Excludes concepts for palliative care or comfort measures.

Constrained to codes in the Intervention, Order: Hospice care ambulatory value set (2.16.840.1.113762.1.4.1108.15)

QDM Datatype and Definition (QDM Version 5.3)

Intervention, Order

Data elements that meet criteria using this datatype should document a request to perform the intervention indicated by the QDM category and its corresponding value set.

Timing: The time the order is signed; Author dateTime

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent patients receiving hospice care outside of a hospital or long term care facility.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Procedure, Order or Intervention, Order. The intent of this value set is to identify all patients receiving hospice care outside of a hospital or long term care facility.
Inclusion Criteria: Includes only relevant concepts associated with hospice care concepts.
Exclusion Criteria: Excludes concepts for palliative care or comfort measures.

Constrained to codes in the Intervention, Performed: Hospice care ambulatory value set (2.16.840.1.113762.1.4.1108.15)

QDM Datatype and Definition (QDM Version 5.3)

Intervention, Performed

Data elements that meet criteria using this datatype should document the completion of the intervention indicated by the QDM category and its corresponding value set.

Timing: The Relevant Period addresses:

  • startTime – the time the intervention begins
  • stopTime – the time the intervention ends

NOTE - timing refers to a single instance of an intervention. If a measure seeks to evaluate multiple interventions over a period of time, the measure developer should use CQL logic to represent the query request.

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / butalbital combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / butalbital (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / butalbital in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Butalbital value set (2.16.840.1.113883.3.464.1003.196.12.1317)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / butalbital / caffeine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / butalbital / caffeine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / butalbital / caffeine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Butalbital / Caffeine value set (2.16.840.1.113883.3.464.1003.196.12.1363)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / butalbital / caffeine / codeine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / butalbital / caffeine / codeine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / butalbital / caffeine / codeine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Butalbital / Caffeine / Codeine value set (2.16.840.1.113883.3.464.1003.196.12.1326)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / dextromethorphan combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / dextromethorphan (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / dextromethorphan in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Chlorpheniramine / Dextromethorphan value set (2.16.840.1.113883.3.464.1003.196.12.1421)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Chlorpheniramine / Dextromethorphan / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1310)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Chlorpheniramine / Dextromethorphan / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1321)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Chlorpheniramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1328)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / chlorpheniramine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / chlorpheniramine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / chlorpheniramine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Chlorpheniramine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1316)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / dexbrompheniramine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dexbrompheniramine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dexbrompheniramine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Dexbrompheniramine value set (2.16.840.1.113883.3.464.1003.196.12.1405)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / dextromethorphan / diphenhydramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dextromethorphan / diphenhydramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dextromethorphan / diphenhydramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Dextromethorphan / Diphenhydramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1399)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / dextromethorphan / doxylamine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dextromethorphan / doxylamine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dextromethorphan / doxylamine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Dextromethorphan / Doxylamine value set (2.16.840.1.113883.3.464.1003.196.12.1338)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / dextromethorphan / doxylamine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / dextromethorphan / doxylamine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / dextromethorphan / doxylamine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Dextromethorphan / Doxylamine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1287)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / diphenhydramine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / diphenhydramine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / diphenhydramine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Diphenhydramine value set (2.16.840.1.113883.3.464.1003.196.12.1350)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent acetaminophen / diphenhydramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; acetaminophen / diphenhydramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; acetaminophen / diphenhydramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Acetaminophen / Diphenhydramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1318)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent amitriptyline / chlordiazepoxide combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amitriptyline / chlordiazepoxide (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amitriptyline / chlordiazepoxide in combination with other medications.

Constrained to codes in the Medication, Order: Amitriptyline / Chlordiazepoxide value set (2.16.840.1.113883.3.464.1003.196.12.1286)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent amitriptyline / perphenazine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amitriptyline / perphenazine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amitriptyline / perphenazine in combination with other medications.

Constrained to codes in the Medication, Order: Amitriptyline / Perphenazine value set (2.16.840.1.113883.3.464.1003.196.12.1428)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent amitriptyline hydrochloride medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amitriptyline hydrochloride only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amitriptyline hydrochloride in combination with other medications.

Constrained to codes in the Medication, Order: Amitriptyline Hydrochloride value set (2.16.840.1.113883.3.464.1003.196.12.1373)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent amoxapine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; amoxapine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; amoxapine in combination with other medications.

Constrained to codes in the Medication, Order: Amoxapine value set (2.16.840.1.113883.3.464.1003.196.12.1273)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent nitrofurantion (anti-infective medications).
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (component, form and strength); generic; human only; prescribable; nitrofurantion medications.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; nitrofurantion in combination with other medications.

Constrained to codes in the Medication, Order: Anti Infectives, other value set (2.16.840.1.113883.3.464.1003.196.12.1481)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent aspirin / butalbital / caffeine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; aspirin / butalbital / caffeine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; aspirin / butalbital / caffeine in combination with other medications.

Constrained to codes in the Medication, Order: Aspirin / Butalbital / Caffeine value set (2.16.840.1.113883.3.464.1003.196.12.1347)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent aspirin / caffeine / orphenadrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; aspirin / caffeine / orphenadrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; aspirin / caffeine / orphenadrine in combination with other medications.

Constrained to codes in the Medication, Order: Aspirin / Caffeine / Orphenadrine value set (2.16.840.1.113883.3.464.1003.196.12.1302)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent atropine / diphenoxylate combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; atropine / diphenoxylate (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; atropine / diphenoxylate in combination with other medications.

Constrained to codes in the Medication, Order: Atropine / Diphenoxylate value set (2.16.840.1.113883.3.464.1003.196.12.1274)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent atropine / hyoscyamine / phenobarbital / scopolamine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; atropine / hyoscyamine / phenobarbital / scopolamine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; atropine / hyoscyamine / phenobarbital / scopolamine in combination with other medications.

Constrained to codes in the Medication, Order: Atropine / Hyoscyamine / Phenobarbital / Scopolamine value set (2.16.840.1.113883.3.464.1003.196.12.1355)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent benztropine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; benztropine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; benztropine in combination with other medications.

Constrained to codes in the Medication, Order: Benztropine value set (2.16.840.1.113883.3.464.1003.196.12.1361)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; brompheniramine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine value set (2.16.840.1.113883.3.464.1003.196.12.1427)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine / codeine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine / Codeine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1409)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine / codeine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine / Codeine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1450)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine / dextromethorphan / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / codeine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / codeine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine / Dextromethorphan / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1325)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine / dextromethorphan / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / dextromethorphan / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / dextromethorphan / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine / Dextromethorphan / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1339)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1327)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent brompheniramine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; brompheniramine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; brompheniramine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Brompheniramine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1332)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent butabarbital medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; butabarbital only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; butabarbital in combination with other medications.

Constrained to codes in the Medication, Order: Butabarbital value set (2.16.840.1.113883.3.464.1003.196.12.1402)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent carbinoxamine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; carbinoxamine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; carbinoxamine in combination with other medications.

Constrained to codes in the Medication, Order: Carbinoxamine value set (2.16.840.1.113883.3.464.1003.196.12.1306)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent carisoprodol medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; carisoprodol only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; carisoprodol in combination with other medications.

Constrained to codes in the Medication, Order: Carisoprodol value set (2.16.840.1.113883.3.464.1003.196.12.1369)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlophedianol / chlorpheniramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlophedianol / chlorpheniramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlophedianol / chlorpheniramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlophedianol / Chlorpheniramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1412)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlophedianol / dexchlorpheniramine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlophedianol / dexchlorpheniramine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlophedianol / dexchlorpheniramine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlophedianol / Dexchlorpheniramine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1447)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine value set (2.16.840.1.113883.3.464.1003.196.12.1352)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / codeine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / codeine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / codeine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Codeine value set (2.16.840.1.113883.3.464.1003.196.12.1301)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / dextromethorphan / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / dextromethorphan / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / dextromethorphan / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Dextromethorphan / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1312)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / dextromethorphan / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / dextromethorphan / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / dextromethorphan / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Dextromethorphan / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1337)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / hydrocodone combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / hydrocodone (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / hydrocodone in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Hydrocodone value set (2.16.840.1.113883.3.464.1003.196.12.1330)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / hydrocodone / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / hydrocodone / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / hydrocodone / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Hydrocodone / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1299)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1343)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / phenylephrine / phenyltoloxamine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / phenylephrine / phenyltoloxamine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / phenylephrine / phenyltoloxamine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Phenylephrine / Phenyltoloxamine value set (2.16.840.1.113883.3.464.1003.196.12.1453)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / phenylephrine / pyrilamine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / phenylephrine / pyrilamine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / phenylephrine / pyrilamine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Phenylephrine / Pyrilamine value set (2.16.840.1.113883.3.464.1003.196.12.1309)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpheniramine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpheniramine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpheniramine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpheniramine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1315)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorpropamide medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorpropamide only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorpropamide in combination with other medications.

Constrained to codes in the Medication, Order: Chlorpropamide value set (2.16.840.1.113883.3.464.1003.196.12.1303)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent chlorzoxazone medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; chlorzoxazone only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; chlorzoxazone in combination with other medications.

Constrained to codes in the Medication, Order: Chlorzoxazone value set (2.16.840.1.113883.3.464.1003.196.12.1362)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent clemastine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; clemastine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; clemastine in combination with other medications.

Constrained to codes in the Medication, Order: Clemastine value set (2.16.840.1.113883.3.464.1003.196.12.1308)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent clomipramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; clomipramine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; clomipramine in combination with other medications.

Constrained to codes in the Medication, Order: Clomipramine value set (2.16.840.1.113883.3.464.1003.196.12.1336)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent conjugated estrogen medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; conjugated estrogen medications.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; conjugated estrogens in combination with other medications.

Constrained to codes in the Medication, Order: Conjugated Estrogens value set (2.16.840.1.113883.3.464.1003.196.12.1357)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent conjugated estrogen / medroxyprogesterone combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; conjugated estrogens / medroxyprogesterone (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; conjugated estrogens / medroxyprogesterone in combination with other medications.

Constrained to codes in the Medication, Order: Conjugated Estrogens / Medroxyprogesterone value set (2.16.840.1.113883.3.464.1003.196.12.1324)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent cyclobenzaprine hydrochloride medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; cyclobenzaprine hydrochloride only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; cyclobenzaprine hydrochloride in combination with other medications.

Constrained to codes in the Medication, Order: Cyclobenzaprine Hydrochloride value set (2.16.840.1.113883.3.464.1003.196.12.1372)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent cyproheptadine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; cyproheptadine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; cyproheptadine in combination with other medications.

Constrained to codes in the Medication, Order: Cyproheptadine value set (2.16.840.1.113883.3.464.1003.196.12.1277)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent desiccated thyroid medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; desiccated thyroid medications.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; desiccated thyroid in combination with other medications, synthetic thyroid hormones (e.g. levothyroxine, liothyronine, thyrolar, tirosint).

Constrained to codes in the Medication, Order: Desiccated Thyroid value set (2.16.840.1.113883.3.464.1003.196.12.1354)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent desipramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; desipramine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; desipramine in combination with other medications.

Constrained to codes in the Medication, Order: Desipramine value set (2.16.840.1.113883.3.464.1003.196.12.1278)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dexbrompheniramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine in combination with other drugs.

Constrained to codes in the Medication, Order: Dexbrompheniramine value set (2.16.840.1.113883.3.464.1003.196.12.1375)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dexbrompheniramine / dextromethorphan / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine / dextromethorphan / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine / dextromethorphan / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Dexbrompheniramine / Dextromethorphan / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1426)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dexbrompheniramine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Dexbrompheniramine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1430)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dexbrompheniramine maleate / pseudoephedrine hydrochloride combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexbrompheniramine maleate / pseudoephedrine hydrochloride (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexbrompheniramine maleate / pseudoephedrine hydrochloride in combination with other medications.

Constrained to codes in the Medication, Order: Dexbrompheniramine Maleate / Pseudoephedrine Hydrochloride value set (2.16.840.1.113883.3.464.1003.196.12.1429)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dexbrompheniramine / dextromethorphan / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexchlorpheniramine / dextromethorphan / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; Dexchlorpheniramine / Dextromethorphan / Pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Dexchlorpheniramine / Dextromethorphan / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1300)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dexbrompheniramine / pseudoephedrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dexchlorpheniramine / pseudoephedrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dexchlorpheniramine / pseudoephedrine in combination with other medications.

Constrained to codes in the Medication, Order: Dexchlorpheniramine / Pseudoephedrine value set (2.16.840.1.113883.3.464.1003.196.12.1425)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dextromethorphan / diphenhydramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dextromethorphan / diphenhydramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dextromethorphan / diphenhydramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Dextromethorphan / Diphenhydramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1397)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dextromethorphan / doxylamine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dextromethorphan / doxylamine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dextromethorphan / doxylamine in combination with other medications.

Constrained to codes in the Medication, Order: Dextromethorphan / Doxylamine value set (2.16.840.1.113883.3.464.1003.196.12.1452)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dicyclomine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dicyclomine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dicyclomine in combination with other medications.

Constrained to codes in the Medication, Order: Dicyclomine value set (2.16.840.1.113883.3.464.1003.196.12.1279)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dienogest / estradiol multiphasic combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dienogest / estradiol multiphasic (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dienogest / estradiol multiphasic in combination with other medications.

Constrained to codes in the Medication, Order: Dienogest / Estradiol Multiphasic value set (2.16.840.1.113883.3.464.1003.196.12.1398)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dimenhydrinate medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dimenhydrinate only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dimenhydrinate in combination with other medications.

Constrained to codes in the Medication, Order: Dimenhydrinate value set (2.16.840.1.113883.3.464.1003.196.12.1500)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent diphenhydramine / ibuprofen combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; diphenhydramine / ibuprofen (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; diphenhydramine / ibuprofen in combination with other medications.

Constrained to codes in the Medication, Order: Diphenhydramine / Ibuprofen value set (2.16.840.1.113883.3.464.1003.196.12.1293)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent diphenhydramine / phenylephrine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; diphenhydramine / phenylephrine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; diphenhydramine / phenylephrine in combination with other medications.

Constrained to codes in the Medication, Order: Diphenhydramine / Phenylephrine value set (2.16.840.1.113883.3.464.1003.196.12.1307)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent diphenhydramine hydrochloride medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; diphenhydramine hydrochloride only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; diphenhydramine hydrochloride in combination with other medications.

Constrained to codes in the Medication, Order: Diphenhydramine Hydrochloride value set (2.16.840.1.113883.3.464.1003.196.12.1371)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent dipyridamole medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; dipyridamole only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; dipyridamole in combination with other medications.

Constrained to codes in the Medication, Order: Dipyridamole value set (2.16.840.1.113883.3.464.1003.196.12.1349)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent disopyramide medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; disopyramide only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; disopyramide in combination with other medications.

Constrained to codes in the Medication, Order: Disopyramide value set (2.16.840.1.113883.3.464.1003.196.12.1311)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent drospirenone / estradiol combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; drospirenone / estradiol (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; drospirenone / estradiol in combination with other medications.

Constrained to codes in the Medication, Order: Drospirenone / Estradiol value set (2.16.840.1.113883.3.464.1003.196.12.1410)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent esterified estrogen medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; esterified estrogen medications.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; esterified estrogens in combination with other medications.

Constrained to codes in the Medication, Order: Esterified Estrogens value set (2.16.840.1.113883.3.464.1003.196.12.1419)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent esterified estrogens / methyltestosterone combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; esterified estrogens / methyltestosterone (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; esterified estrogens / methyltestosterone in combination with other medications.

Constrained to codes in the Medication, Order: Esterified Estrogens / Methyltestosterone value set (2.16.840.1.113883.3.464.1003.196.12.1320)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent estradiol medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; estradiol only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; estradiol in combination with other medications.

Constrained to codes in the Medication, Order: Estradiol value set (2.16.840.1.113883.3.464.1003.196.12.1365)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent estradiol / norethindrone combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; estradiol / norethindrone (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; estradiol / norethindrone in combination with other medications.

Constrained to codes in the Medication, Order: Estradiol / Norethindrone value set (2.16.840.1.113883.3.464.1003.196.12.1323)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent estropipate medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; estropipate only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; estropipate in combination with other medications.

Constrained to codes in the Medication, Order: Estropipate value set (2.16.840.1.113883.3.464.1003.196.12.1319)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent glyburide medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; glyburide only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; glyburide in combination with other medications.

Constrained to codes in the Medication, Order: Glyburide value set (2.16.840.1.113883.3.464.1003.196.12.1368)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent glyburide / metformin combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; glyburide / metformin (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; glyburide / metformin in combination with other medications.

Constrained to codes in the Medication, Order: Glyburide / Metformin value set (2.16.840.1.113883.3.464.1003.196.12.1360)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent guanfacine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; guanfacine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; guanfacine in combination with other medications.

Constrained to codes in the Medication, Order: Guanfacine value set (2.16.840.1.113883.3.464.1003.196.12.1341)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent high risk medications at any dose and for any duration for the elderly.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human only; prescribable; medications considered high risk for the elderly.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable medications.

Constrained to codes in the Medication, Order: High Risk Medications for the Elderly value set (2.16.840.1.113883.3.464.1003.196.12.1253)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent high risk medications at any dose with greater than a 90-day supply for the elderly.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human only; prescribable; high risk drugs at any dose with greater than a 90-day supply for the elderly.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable medications.

Constrained to codes in the Medication, Order: High-Risk Medications With Days Supply Criteria value set (2.16.840.1.113883.3.464.1003.196.12.1254)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent glyburide / metformin combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hydrochlorothiazide / methyldopa (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hydrochlorothiazide / methyldopa in combination with other medications.

Constrained to codes in the Medication, Order: Hydrochlorothiazide / Methyldopa value set (2.16.840.1.113883.3.464.1003.196.12.1414)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent hydroxyzine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hydroxyzine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hydroxyzine in combination with other medications.

Constrained to codes in the Medication, Order: Hydroxyzine value set (2.16.840.1.113883.3.464.1003.196.12.1374)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent hyoscyamine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine in combination with other medications.

Constrained to codes in the Medication, Order: Hyoscyamine value set (2.16.840.1.113883.3.464.1003.196.12.1501)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent hyoscyamine / methenamine / mblue / phenyl salicyl combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl in combination with other medications.

Constrained to codes in the Medication, Order: Hyoscyamine / Methenamine / Mblue / Phenyl Salicyl value set (2.16.840.1.113883.3.464.1003.196.12.1503)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent hyoscyamine / methenamine / mblue / phenyl salicyl / sodium biphosphate combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl / sodium biphosphate (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine / methenamine / mblue / phenyl salicyl / sodium biphosphate in combination with other medications.

Constrained to codes in the Medication, Order: Hyoscyamine / Methenamine / Mblue / Phenyl Salicyl / Sodium Biphosphate value set (2.16.840.1.113883.3.464.1003.196.12.1504)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent hyoscyamine / methenamine / mblue / sodium biphosphate combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hyoscyamine / methenamine / mblue / sodium biphosphate (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hyoscyamine / methenamine / mblue / sodium biphosphate in combination with other medications.

Constrained to codes in the Medication, Order: Hyoscyamine / Methenamine / Mblue / Sodium Biphosphate value set (2.16.840.1.113883.3.464.1003.196.12.1505)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent imipramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; imipramine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; imipramine in combination with other medications.

Constrained to codes in the Medication, Order: Imipramine value set (2.16.840.1.113883.3.464.1003.196.12.1359)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent indomethacin medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; indomethacin only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; indomethacin in combination with other medications.

Constrained to codes in the Medication, Order: Indomethacin value set (2.16.840.1.113883.3.464.1003.196.12.1366)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent isoxsuprine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; isoxsuprine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; isoxsuprine in combination with other medications.

Constrained to codes in the Medication, Order: Isoxsuprine value set (2.16.840.1.113883.3.464.1003.196.12.1422)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent ketorolac tromethamine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; ketorolac tromethamine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; ketorolac tromethamine in combination with other medications.

Constrained to codes in the Medication, Order: Ketorolac Tromethamine value set (2.16.840.1.113883.3.464.1003.196.12.1364)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent medication concepts considered as high risk for the elderly.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; medications considered high risk for the elderly.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable medications.

Constrained to codes in the Medication, Order: List of Single RxNorm Code Concepts for High Risk Drugs for the Elderly value set (2.16.840.1.113883.3.464.1003.196.12.1272)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent meclizine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; meclizine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; meclizine in combination with other medications.

Constrained to codes in the Medication, Order: Meclizine value set (2.16.840.1.113883.3.464.1003.196.12.1506)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent megestrol medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs; generic; human use only; prescribable; megestrol only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; megestrol in combination with other medications.

Constrained to codes in the Medication, Order: Megestrol value set (2.16.840.1.113883.3.464.1003.196.12.1342)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent meperidine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; meperidine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; meperidine in combination with other medications.

Constrained to codes in the Medication, Order: Meperidine value set (2.16.840.1.113883.3.464.1003.196.12.1351)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent meprobamate medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; meprobamate only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; meprobamate in combination with other medications.

Constrained to codes in the Medication, Order: Meprobamate value set (2.16.840.1.113883.3.464.1003.196.12.1284)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent metaxalone medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; metaxalone only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; metaxalone in combination with other medications.

Constrained to codes in the Medication, Order: Metaxalone value set (2.16.840.1.113883.3.464.1003.196.12.1358)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent methocarbamol medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; methocarbamol only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; methocarbamol in combination with other medications.

Constrained to codes in the Medication, Order: Methocarbamol value set (2.16.840.1.113883.3.464.1003.196.12.1370)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent methyldopa medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; methyldopa only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; methyldopa in combination with other medications.

Constrained to codes in the Medication, Order: Methyldopa value set (2.16.840.1.113883.3.464.1003.196.12.1331)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent nifedipine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; nifedipine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; nifedipine in combination with other medications.

Constrained to codes in the Medication, Order: Nifedipine value set (2.16.840.1.113883.3.464.1003.196.12.1353)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent nonbenzodiazepine hypnotic medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; nonbenzodiazepine hypnotic medications.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; benzodiazepine derivative medications.

Constrained to codes in the Medication, Order: Nonbenzodiazepine hypnotics value set (2.16.840.1.113883.3.464.1003.196.12.1480)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent nortriptyline medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; nortriptyline only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; nortriptyline in combination with other medications.

Constrained to codes in the Medication, Order: Nortriptyline value set (2.16.840.1.113883.3.464.1003.196.12.1507)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent paroxetine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; paroxetine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; paroxetine in combination with other medications.

Constrained to codes in the Medication, Order: Paroxetine value set (2.16.840.1.113883.3.464.1003.196.12.1508)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent phenobarbital medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; phenobarbital only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; Phenobarbital in combination with other medications.

Constrained to codes in the Medication, Order: Phenobarbital value set (2.16.840.1.113883.3.464.1003.196.12.1348)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent promethazine hydrochloride medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; promethazine hydrochloride only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; promethazine hydrochloride in combination with other medications.

Constrained to codes in the Medication, Order: Promethazine Hydrochloride value set (2.16.840.1.113883.3.464.1003.196.12.1367)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent protriptyline medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; protriptyline only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; protriptyline in combination with other medications.

Constrained to codes in the Medication, Order: Protriptyline value set (2.16.840.1.113883.3.464.1003.196.12.1509)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent pseudoephedrine / triprolidine combination medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; pseudoephedrine / triprolidine (combination medication).
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; pseudoephedrine / triprolidine in combination with other medications.

Constrained to codes in the Medication, Order: Pseudoephedrine / Triprolidine value set (2.16.840.1.113883.3.464.1003.196.12.1345)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent trihexyphenidyl medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; trihexyphenidyl only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; trihexyphenidyl in combination with other medications.

Constrained to codes in the Medication, Order: Trihexyphenidyl value set (2.16.840.1.113883.3.464.1003.196.12.1334)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent trimipramine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; trimipramine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; trimipramine in combination with other medications.

Constrained to codes in the Medication, Order: Trimipramine value set (2.16.840.1.113883.3.464.1003.196.12.1285)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent triprolidine medications.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; triprolidine only.
Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; triprolidine in combination with other medications.

Constrained to codes in the Medication, Order: Triprolidine value set (2.16.840.1.113883.3.464.1003.196.12.1408)

QDM Datatype and Definition (QDM Version 5.3)

Medication, Order

Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.

Timing: The Author dateTime is the time the order is signed.

Timing: The Relevant Period addresses:

  • startTime - when the first administration of the medication is expected. The first administration may be expected at the time of the order or at a specified future date (i.e., the active time for the order); such information should be identified in the medication order. If the startTime is not specified in the order, the startTime defaults to the Author dateTime (the time the order is signed).
  • stopTime - when the medication supply provided by the medication order is expected to be completed, including all fulfillments covered by the number of refills.

Note that when calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the Relevant Period start and stop times multiplied by (1 + the number of refills).

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent whether the patient is Hispanic or not; ethnicity category defined by the Centers for Disease Control and Prevention and National Center for Health Statistics.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Ethnicity.
Inclusion Criteria: Includes only relevant concepts associated with ethnicity defined as Hispanic or Latino, or Not Hispanic or Latino.
Exclusion Criteria: No exclusions.

Constrained to codes in the Patient Characteristic Ethnicity: Ethnicity value set (2.16.840.1.114222.4.11.837)

QDM Datatype and Definition (QDM Version 5.3)

Patient Characteristic Ethnicity

Data elements that meet criteria using this datatype should document that the patient has one or more of the ethnicities indicated by the QDM category and its corresponding value set.

Timing: Ethnicity does not have a specific timing. Measures using Patient Characteristic, Ethnicity should address the most recent entry in the clinical record.

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent categories of types of health care payor entities as defined by the US Public Health Data Consortium SOP code system.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Payer.
Inclusion Criteria: Includes only relevant concepts associated with payer codes in the code system.
Exclusion Criteria: No exclusions.

Constrained to codes in the Patient Characteristic Payer: Payer value set (2.16.840.1.114222.4.11.3591)

QDM Datatype and Definition (QDM Version 5.3)

Patient Characteristic Payer

Data elements that meet criteria using this datatype should document that the patient has one or more of the payers indicated by the QDM category and its corresponding value set.

Timing: The Relevant Period addresses:

  • startTime – the first day of insurance coverage with the referenced payer
  • stopTime – the last day of insurance coverage with the referenced payer

 

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent the general race category reported by the patient - subject may have more than one; defined by the Centers for Disease Control and Prevention and National Center for Health Statistics.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Race.
Inclusion Criteria: Includes only relevant concepts associated with the following race categories: American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, Other Race, White.
Exclusion Criteria: No exclusions.

Constrained to codes in the Patient Characteristic Race: Race value set (2.16.840.1.114222.4.11.836)

QDM Datatype and Definition (QDM Version 5.3)

Patient Characteristic Race

Data elements that meet criteria using this datatype should document the patient’s race.

Timing: Race does not have a specific timing. Measures using Patient Characteristic, Race should address the most recent entry in the clinical record.

Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent gender identity restricted to only male and female used in administrative situations requiring a restriction to these two categories.
Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Patient Characteristic Sex.
Inclusion Criteria: Includes relevant concepts associated with gender concepts for male and female only.
Exclusion Criteria: Excludes any gender identity that is not male or female.

Constrained to codes in the Patient Characteristic Sex: ONC Administrative Sex value set (2.16.840.1.113762.1.4.1)

QDM Datatype and Definition (QDM Version 5.3)

Patient Characteristic Sex

Data elements that meet criteria using this datatype should document that the patient's sex matches the QDM category and its corresponding value set.

Timing: Birth (administrative) sex does not have a specific timing.